| | | 54306 | | 27.08.1997 | | GlaxoSmithKline AG | | 25.10.2007 | | | | | 24.10.2022 | | | | | | 03.04.40. | | | | 03.04.40. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Axotide 0,125 mg | Dosier-Aerosol (FCKW-frei) | () + () + Metered dose aerosol () | R03BA05 | CI | | 02 | Axotide 0,250 mg | Dosier-Aerosol (FCKW-frei) | () + () + Metered dose aerosol () | R03BA05 | CI | | 04 | Axotide 0,050 mg | Dosier-Aerosol (FCKW-frei) | () + () + Metered dose aerosol () | R03BA05 | CI |
|
|
